Cost-effectiveness analysis of parenting interventions for the prevention of behaviour problems in children.
Adaptation, Psychological
Adolescent
Adult
Attention Deficit and Disruptive Behavior Disorders
/ economics
Bibliotherapy
/ economics
Child
Child, Preschool
Conduct Disorder
Cost-Benefit Analysis
Education, Nonprofessional
/ economics
Female
Follow-Up Studies
Health Care Costs
/ statistics & numerical data
Humans
Implosive Therapy
/ economics
Learning
Male
Parenting
Parents
/ education
Problem Behavior
/ psychology
Quality-Adjusted Life Years
Sweden
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
06
2019
accepted:
05
11
2019
entrez:
3
12
2019
pubmed:
4
12
2019
medline:
27
3
2020
Statut:
epublish
Résumé
Behavior problems are common among children and place a high disease and financial burden on individuals and society. Parenting interventions are commonly used to prevent such problems, but little is known about their possible longer-term economic benefits. This study modelled the longer-term cost-effectiveness of five parenting interventions delivered in a Swedish context: Comet, Connect, the Incredible Years (IY), COPE, bibliotherapy, and a waitlist control, for the prevention of persistent behavior problems. A decision analytic model was developed and used to forecast the cost per averted disability-adjusted life-year (DALY) by each parenting intervention and the waitlist control, for children aged 5-12 years. Age-specific cohorts were modelled until the age of 18. Educational and health care sector costs related to behavior problems were included. Active interventions were compared to the waitlist control as well as to each other. Intervention costs ranged between US$ 14 (bibliotherapy) to US$ 1,300 (IY) per child, with effects of up to 0.23 averted DALYs per child (IY). All parenting interventions were cost-effective at a threshold of US$ 15,000 per DALY in relation to the waitlist control. COPE and bibliotherapy strongly dominated the other options, and an additional US$ 2,629 would have to be invested in COPE to avert one extra DALY, in comparison to bibliotherapy. Parenting interventions are cost-effective in the longer run in comparison to a waitlist control. Bibliotherapy or COPE are the most efficient options when comparing interventions to one another. Optimal decision for investment should to be based on budget considerations and priority settings.
Sections du résumé
BACKGROUND
Behavior problems are common among children and place a high disease and financial burden on individuals and society. Parenting interventions are commonly used to prevent such problems, but little is known about their possible longer-term economic benefits. This study modelled the longer-term cost-effectiveness of five parenting interventions delivered in a Swedish context: Comet, Connect, the Incredible Years (IY), COPE, bibliotherapy, and a waitlist control, for the prevention of persistent behavior problems.
METHODS
A decision analytic model was developed and used to forecast the cost per averted disability-adjusted life-year (DALY) by each parenting intervention and the waitlist control, for children aged 5-12 years. Age-specific cohorts were modelled until the age of 18. Educational and health care sector costs related to behavior problems were included. Active interventions were compared to the waitlist control as well as to each other.
RESULTS
Intervention costs ranged between US$ 14 (bibliotherapy) to US$ 1,300 (IY) per child, with effects of up to 0.23 averted DALYs per child (IY). All parenting interventions were cost-effective at a threshold of US$ 15,000 per DALY in relation to the waitlist control. COPE and bibliotherapy strongly dominated the other options, and an additional US$ 2,629 would have to be invested in COPE to avert one extra DALY, in comparison to bibliotherapy.
CONCLUSIONS
Parenting interventions are cost-effective in the longer run in comparison to a waitlist control. Bibliotherapy or COPE are the most efficient options when comparing interventions to one another. Optimal decision for investment should to be based on budget considerations and priority settings.
Identifiants
pubmed: 31790442
doi: 10.1371/journal.pone.0225503
pii: PONE-D-19-18050
pmc: PMC6886776
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0225503Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMJ. 2001 Jul 28;323(7306):191
pubmed: 11473907
Prev Sci. 2015 May;16(4):586-96
pubmed: 25382415
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Clin Child Psychol Psychiatry. 2019 Jan;24(1):144-157
pubmed: 30101599
BMJ. 2007 Mar 31;334(7595):682
pubmed: 17350965
Child Dev. 1990 Jun;61(3):893-910
pubmed: 2364762
J Child Psychol Psychiatry. 2010 Jan;51(1):48-57
pubmed: 19732250
J Consult Clin Psychol. 2015 Dec;83(6):1069-1084
pubmed: 26009784
Soc Psychiatry Psychiatr Epidemiol. 2013 Feb;48(2):337-44
pubmed: 22699685
J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
J Abnorm Child Psychol. 2017 Apr;45(3):527-542
pubmed: 27334706
Eur Child Adolesc Psychiatry. 2007 Aug;16(5):316-26
pubmed: 17483870
J Atten Disord. 2010 May;13(6):618-28
pubmed: 19365087
Behav Ther. 2010 Dec;41(4):530-42
pubmed: 21035616
J Child Psychol Psychiatry. 2013 Sep;54(9):977-85
pubmed: 23442096
J Child Psychol Psychiatry. 1995 Oct;36(7):1141-59
pubmed: 8847377
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Eur Child Adolesc Psychiatry. 2018 Oct;27(10):1239-1260
pubmed: 28983792
Clin Psychol Rev. 2006 Jan;26(1):86-104
pubmed: 16280191
Lancet Psychiatry. 2014 Oct;1(5):377-387
pubmed: 26114092
Aust N Z J Psychiatry. 2007 Mar;41(3):239-46
pubmed: 17464705
Health Econ Rev. 2015 Dec;5(1):40
pubmed: 26690366
Eur J Health Econ. 2013 Feb;14(1):85-94
pubmed: 21853340
Child Care Health Dev. 2016 Jul;42(4):521-33
pubmed: 27272608
J Child Psychol Psychiatry. 2013 Dec;54(12):1263-74
pubmed: 24117530
J Ment Health Policy Econ. 2016 Dec 1;19(4):201-212
pubmed: 27991419
Acta Psychiatr Scand. 2016 Dec;134(6):533-545
pubmed: 27714770
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Evid Based Child Health. 2013 Mar 7;8(2):318-692
pubmed: 23877886
BMC Public Health. 2011 Oct 14;11:803
pubmed: 21999434
Pharmacoeconomics. 2015 Nov;33(11):1229-36
pubmed: 26093889
Eur J Health Econ. 2013 Dec;14(6):939-45
pubmed: 23179162
Lancet Psychiatry. 2018 Mar;5(3):237-286
pubmed: 29482764
Eur Child Adolesc Psychiatry. 2014 Jun;23(6):393-408
pubmed: 24399038
Psychol Med. 2019 Apr;49(5):828-842
pubmed: 30017006
Lancet Psychiatry. 2018 Apr;5(4):299-300
pubmed: 29580605
Child Adolesc Psychiatry Ment Health. 2013 Oct 11;7(1):34
pubmed: 24119376
J Clin Child Adolesc Psychol. 2004 Mar;33(1):105-24
pubmed: 15028546
J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):841-50
pubmed: 27663939
Eur Child Adolesc Psychiatry. 2018 Jul;27(7):933-944
pubmed: 29288334